Allelica’s software empowers health systems to reduce the burden of chronic disease through revolutionary preventive healthcare tools powered by the integration of patients’ clinical and genomic data.
Allelica’s end-to-end Polygenic Risk Score pipeline provides clinical laboratories with a secure infrastructure for PRS analysis through to clinical reporting and can determine a patients’ absolute risk of common diseases through a simple file upload of their genotyped data.
Enabling cutting-edge research
Allelica’s PRS modules for new score discovery and validation perform the work of a team of bioinformaticians, enabling researchers to generate the best performing PRS using multiple gold standard algorithms in parallel and achieve publication ready results without months of bioinformatics efforts.
“With this agreement, Merck confirms its strong commitment in advancing Science and Technology in the therapeutic area of cardiovascular disorders.”
Antonio Messina, Merck General ManagerRead more →
Head of Genomics Program NGS
Chairman of the Board, Medipredict Chairman of the Board,
Center for Preventive Medicine & Longevity Director,
Center for Preventive Medicine & Longevity
Our products are developed and validated using world class datasets and state-of-the-art technology to ensure the highest level of quality.
We are a group of international scientists and researchers committed to maintaining standards of academic excellence every step of the way.
Everything we do works towards our common goal of providing tangible improvement in preventive healthcare to help humans live a longer, healthier life.
Allelica's Polygenic Risk Scores for common diseases have the highest predictive power on the market, allowing physicians to more effectively help patients lower their risk of life-threatening diseases.
Our secure digital platform enables researchers to construct and validate new Polygenic Risk Scores on multiple populations using the top algorithms in parallel to reveal the best Polygenic Risk Scores.